Novo Nordisk CEO agrees to testify

News

Novo Nordisk ousts CEO

Novo Nordisk CEO to step down amid market challenges

Novo Nordisk (NVO) stock falls as the company CEO Lars Fruergaard Jørgensen steps down after 8 years of leadership marked by surging profits & sales. Read more here.

MarketWatch on MSN · 1d

Novo Nordisk rode Ozempic’s success to becoming Europe’s top company. Now it’s faltering and its CEO is out.

Lars Fruergaard Jorgensen, the chief executive of once-highflying Danish drugmaker Novo Nordisk, is stepping down after eight years in the role, the maker of Ozempic and Wegovy drugs announced on Friday.

CBS News on MSN · 1d

Novo Nordisk CEO Lars Jorgensen, who led company into weight loss drugs, to step down

Novo Nordisk, maker of weight loss drug Wegovy, says CEO Lars Fruergaard Jorgensen is leaving the company by "mutual agreement."

pharmaphorum8d

Novo Nordisk CEO agrees to testify on semaglutide pricing

Novo Nordisk’ chief executive Lars Fruergaard Jørgensen has agreed to appear at a Senate ... representative in the GLP-1 agonist market to testify at the hearing. AstraZeneca's run of positive ...

Hosted on MSN11mon

Novo Nordisk CEO to testify before Senate on Ozempic pricing

Norvo Nordisk (NVO) (OTCPK ... after the Danish pharma giant’s CEO agreed to testify before the Senate later this year. Sen. Bernie Sanders (I-Vt.), the chairman of the Senate Committee on ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending on Bing

News

Novo Nordisk ousts CEO

Related topics